was read the article
array:24 [ "pii" => "S0873215915303469" "issn" => "08732159" "doi" => "10.1016/S0873-2159(15)30346-9" "estado" => "S350" "fechaPublicacion" => "2007-03-01" "aid" => "4" "copyright" => "Sociedade Portuguesa de Pneumologia/SPP" "copyrightAnyo" => "2007" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2007;13:239-54" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2222 "formatos" => array:3 [ "EPUB" => 194 "HTML" => 1361 "PDF" => 667 ] ] "itemSiguiente" => array:19 [ "pii" => "S0873215915303445" "issn" => "08732159" "doi" => "10.1016/S0873-2159(15)30344-5" "estado" => "S350" "fechaPublicacion" => "2007-03-01" "aid" => "2" "copyright" => "Sociedade Portuguesa de Pneumologia/SPP" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2007;13:175-212" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2274 "formatos" => array:3 [ "EPUB" => 197 "HTML" => 1399 "PDF" => 678 ] ] "pt" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Prémio Thomé Villar / Boehringer Ingelheim 2005 (Secção A) / Thomé Villar / Boehringer Ingelheim Award 2005 (Section A)</span>" "titulo" => "Pulmão profundo – Reacção celular ao VIH" "tienePdf" => "pt" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "pt" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "175" "paginaFinal" => "212" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Deep lung – Cellular reaction to HIV" ] ] "contieneResumen" => array:2 [ "pt" => true "en" => true ] "contienePdf" => array:1 [ "pt" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Maria Alcide Tavares Marques, Vera Alves, Victor Duque, M. Filomena Botelho" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Maria Alcide Tavares" "apellidos" => "Marques" ] 1 => array:2 [ "nombre" => "Vera" "apellidos" => "Alves" ] 2 => array:2 [ "nombre" => "Victor" "apellidos" => "Duque" ] 3 => array:2 [ "nombre" => "M. Filomena" "apellidos" => "Botelho" ] ] ] ] ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915303445?idApp=UINPBA00004E" "url" => "/08732159/0000001300000002/v1_201509071322/S0873215915303445/v1_201509071322/pt/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0873215915303433" "issn" => "08732159" "doi" => "10.1016/S0873-2159(15)30343-3" "estado" => "S350" "fechaPublicacion" => "2007-03-01" "aid" => "1" "copyright" => "Sociedade Portuguesa de Pneumologia/SPP" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Rev Port Pneumol. 2007;13:173" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1832 "formatos" => array:3 [ "EPUB" => 208 "HTML" => 1031 "PDF" => 593 ] ] "pt" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial / Editorial</span>" "titulo" => "Tempo de mudança" "tienePdf" => "pt" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "173" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Time to change" ] ] "contienePdf" => array:1 [ "pt" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Renato Sotto-Mayor" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Renato" "apellidos" => "Sotto-Mayor" ] ] ] ] ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915303433?idApp=UINPBA00004E" "url" => "/08732159/0000001300000002/v1_201509071322/S0873215915303433/v1_201509071322/pt/main.assets" ] "pt" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original / Original Article</span>" "titulo" => "Hipertensão arterial pulmonar – Experiência do Centro Hospitalar de Vila Nova de Gaia" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "239" "paginaFinal" => "254" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Ana Oliveira, Daniela Ferreira, António Caiado, Susana Ferreira, Paula Ferreira, Lino Santos, Manuel Gonçalves, Teresa Shiang" "autores" => array:8 [ 0 => array:3 [ "nombre" => "Ana" "apellidos" => "Oliveira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "af0005" ] ] ] 1 => array:3 [ "nombre" => "Daniela" "apellidos" => "Ferreira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "af0005" ] ] ] 2 => array:3 [ "nombre" => "António" "apellidos" => "Caiado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">2</span>" "identificador" => "af0010" ] ] ] 3 => array:3 [ "nombre" => "Susana" "apellidos" => "Ferreira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "af0005" ] ] ] 4 => array:3 [ "nombre" => "Paula" "apellidos" => "Ferreira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "af0005" ] ] ] 5 => array:3 [ "nombre" => "Lino" "apellidos" => "Santos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">3</span>" "identificador" => "af0015" ] ] ] 6 => array:3 [ "nombre" => "Manuel" "apellidos" => "Gonçalves" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">4</span>" "identificador" => "af0020" ] ] ] 7 => array:3 [ "nombre" => "Teresa" "apellidos" => "Shiang" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">5</span>" "identificador" => "af0025" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Interna Complementar de Pneumologia / <span class="elsevierStyleItalic">Pulmonolgy resident</span>" "etiqueta" => "1" "identificador" => "af0005" ] 1 => array:3 [ "entidad" => "Assistente Hospitalar de Pneumologia / <span class="elsevierStyleItalic">Pulmonolgy consultant</span>" "etiqueta" => "2" "identificador" => "af0010" ] 2 => array:3 [ "entidad" => "Assistente Hospitalar de Cardiologia / <span class="elsevierStyleItalic">Cardiology consultant</span>" "etiqueta" => "3" "identificador" => "af0015" ] 3 => array:3 [ "entidad" => "Assistente Hospitalar Graduado de Medicina Interna / <span class="elsevierStyleItalic">Internal Medicine specialist consultant</span>" "etiqueta" => "4" "identificador" => "af0020" ] 4 => array:3 [ "entidad" => "Assistente Hospitalar Graduada de Pneumologia / <span class="elsevierStyleItalic">Pulmonolgy specialist consultant</span>" "etiqueta" => "5" "identificador" => "af0025" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Pulmonary arterial hypertension – Experience of Centro Hospitalar de Vila Nova de Gaia" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2006-10-04" "fechaAceptado" => "2007-01-02" "tieneResumen" => true "resumen" => array:2 [ "pt" => array:2 [ "titulo" => "Resumo" "resumen" => "<span id="as0005" class="elsevierStyleSection elsevierViewall"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Introdução:</span> A hipertensão arterial pulmonar (HAP) é uma doença grave e progressiva potencialmente fatal em poucos anos. Até à década de 90, o único tratamento eficaz para esta entidade era o transplante pul-monar/cardiopulmonar. Nos últimos anos assistiu-se ao aparecimento de novos fármacos que vieram alte-rar o curso da doença.</p><p id="sp0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Objectivos:</span> Caracterização dos doentes com HAP observados no Centro Hospitalar de VN Gaia no período de 2000 a 2006. Alertar para esta entidade.</p><p id="sp0015" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Material e métodos:</span> Análise retrospectiva de todos os doentes com HAP ou doença tromboembólica crónica em tratamento no CHVN Gaia.</p><p id="sp0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Resultados</span>: No referido período foram observados 11 doentes, 7 mulheres e 4 homens, com média etária de 43 anos. Cinco doentes com HAP idiopática, três com doença tromboembólica crónica, dois com HAP associada a comunicação interauricular e um com HAP associada a S. CREST. Ao diagnóstico, a maioria en-contravase em classe funcional NYHA/OMS III/IV, a pressão sistólica média da artéria pulmonar foi de 98<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>32<span class="elsevierStyleHsp" style=""></span>mmHg e a distância média percorrida na 6-MWT foi de 401<span class="elsevierStyleHsp" style=""></span>m. Terapêutica inicial: Três doentes iloprost por via inalatória; dois treprostinil subcutâneo; três bosentan <span class="elsevierStyleItalic">per os</span>; um sildenafil <span class="elsevierStyleItalic">per os</span> e dois doentes foram submetidos a cirurgia. O tempo médio de <span class="elsevierStyleItalic">follow-up</span> é de 28,1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>20.3 meses. Cinco doentes melhoraram, três mantiveram-se estáveis, um agravou e dois faleceram.</p><p id="sp0025" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclusão</span>: A HAP é uma doença grave que requer uma abordagem multidisciplinar com necessidade de terapêuticas complexas e dispendiosas. O diagnóstico em estádios precoces é essencial, de modo a permitir uma terapêutica atempada.</p><p id="sp0030" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2007; XIII (2): 239-254</span></p></span>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="as0010" class="elsevierStyleSection elsevierViewall"><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Introduction:</span> Pulmonary arterial hypertension (PAH) is a serious and progressive disease, potentially fatal in a few years. Until the 1990s the only effective treatment for this disease was pulmonary/cardiopulmo-nary transplant. Over the last few years several drugs have emerged that have modified the course of the disease.</p><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Aims:</span> To characterise patients with PAH followed at Centro Hospitalar de V.N.Gaia between 2000 and 2006. To raise awareness of this entity.</p><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Material and methods:</span> Retrospective analysis of all patients with PAH or chronic thromboembolic pulmonary hypertension (CTEPH) followed at our Hospital.</p><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Results:</span> In this period 11 patients were observed, 7 women and 4 men, with a mean age of 43 y. Five patients had idiopathic PAH, three had CTEPH, two had PAH associated with interauricular communication and one had PAH associated with CREST Syndrome.</p><p id="sp0055" class="elsevierStyleSimplePara elsevierViewall">At the time of diagnosis most patients were in NYHA/ /WHO Functional Class III/IV, mean systolic pulmonary artery pressure was 98<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>32<span class="elsevierStyleHsp" style=""></span>mmHg and mean distance walked in the 6-minute walk test was 401<span class="elsevierStyleHsp" style=""></span>m. Initial treatment: Three patients had inhaled iloprost, two subcutaneous treprostinil, three oral bosentan, one oral sildenafil and two patients under-went surgery. Mean follow-up time was 28.1<span class="elsevierStyleHsp" style=""></span>months. Five patients recovered, three are stable, one worsened and two died.</p><p id="sp0060" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclusions</span>: PAH is a serious illness which requires a multidisciplinary approach with the need for complex and expensive therapies. Diagnosis in initial stages is essential for an effective treatment.</p><p id="sp0065" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2007; XIII (2): 239-254</span></p></span>" ] ] "lecturaRecomendada" => array:1 [ 0 => array:3 [ "vista" => "all" "titulo" => "<span class="elsevierStyleSectionTitle" id="st0015">Bibliografia / Bibliography</span>" "seccion" => array:1 [ 0 => array:2 [ "vista" => "all" "bibliografiaReferencia" => array:25 [ 0 => array:3 [ "identificador" => "bb0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "for The Task Force On Diagnosis And Treatment Of Pulmonary Arterial Hypertension Of The European Society Of Cardiology. Guidelines On Diagnosis And Treatment Of Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "N. Galié" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur J Cardiol" "fecha" => "2004" "volumen" => "25" "paginaInicial" => "2243" "paginaFinal" => "2278" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bb0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical Classification of Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "G. Simonneau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2004" "volumen" => "43" "paginaInicial" => "S5" "paginaFinal" => "S12" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bb0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "S. Hatano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "titulo" => "Primary Pulmonary Hypertension" "fecha" => "1975" "editorial" => "WHO" "editorialLocalizacion" => "Geneva" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bb0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.J. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199701093360207" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1997" "volumen" => "336" "paginaInicial" => "111" "paginaFinal" => "117" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8988890" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bb0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.P. Gaine" 1 => "L.J. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(98)02111-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1998" "volumen" => "352" "paginaInicial" => "719" "paginaFinal" => "725" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9729004" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bb0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug Therapy For Pulmonary Arterial Hyper-tension: What’s On The Menu Today?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Mehta" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2003" "volumen" => "124" "paginaInicial" => "2045" "paginaFinal" => "2049" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14665473" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bb0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and Management of Pulmonary Artery Hypertension: ACCP Evidence-Based Clinical Practice Guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "L.J. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Chest" "fecha" => "2004" "volumen" => "126" "paginaInicial" => "1S" "paginaFinal" => "92S" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bb0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prostanoids For Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Galie" 1 => "A. Manes" 2 => "A. Branzi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Respir Med" "fecha" => "2003" "volumen" => "2" "paginaInicial" => "123" "paginaFinal" => "137" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14720012" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bb0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A Comparison Of Continuous Intravenous Epoprostenol (Prostacyclin) With Conventional Therapy For Primary Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:2 [ 0 => "R.J. Barst" 1 => "L. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199602013340504" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1996" "volumen" => "334" "paginaInicial" => "296" "paginaFinal" => "301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8532025" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bb0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcome in 91 Consecutive Patients with Pulmonary Arterial Hypertension Receiving Epoprostenol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "K.P. Kuhn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200204-333OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2003" "volumen" => "167" "paginaInicial" => "580" "paginaFinal" => "586" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12446266" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bb0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Survival in Primary Pulmonary Hypertension – The Impact of Epoprostenol Therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "V. McLaughlin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2002" "volumen" => "106" "paginaInicial" => "1477" "paginaFinal" => "1482" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12234951" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bb0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "for The Aerosolized Iloprost Randomized (AIR) Study Group. Inhaled Iloprost For Severe Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "H. Olschewski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa020204" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2002" "volumen" => "347" "paginaInicial" => "322" "paginaFinal" => "329" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12151469" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bb0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-Term Treatment Of Primary Pulmonary Hypertension With Aerosolized Iloprost, A Prostacyclin Analogue" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Hoeper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200006223422503" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "342" "paginaInicial" => "1866" "paginaFinal" => "1870" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10861321" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bb0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension: A Prospective, Multicenter, Open-Label, 12-Week Trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "V.F. Tapson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.129.3.683" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "683" "paginaFinal" => "688" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16537868" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bb0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuous Subcutaneous Infusion Of Treprostinil, A Prostacyclin Analogue, In Patients With Pulmonary Arterial Hypertension: A Double-Blind, Randomized, Placebo-Con-trolled Trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "G. Simonneau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.165.6.2106079" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2002" "volumen" => "165" "paginaInicial" => "800" "paginaFinal" => "804" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11897647" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bb0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bosentan Therapy For Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "L.J. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa012212" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2002" "volumen" => "346" "paginaInicial" => "896" "paginaFinal" => "903" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11907289" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bb0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension – A 1-Year Follow-up Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "O. Sitbon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2003" "volumen" => "124" "paginaInicial" => "247" "paginaFinal" => "254" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12853530" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bb0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Survival With First-Line Bosentan In Patients With Primary Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "V. McLaughlin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.05.00054804" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "244" "paginaFinal" => "249" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15684287" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bb0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Hoeper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.128.4.2363" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "2363" "paginaFinal" => "2367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16236895" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bb0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "E.D. Michelakis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.CIR.0000099502.17776.C2" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2003" "volumen" => "108" "paginaInicial" => "2066" "paginaFinal" => "2069" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14568893" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bb0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "for the Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "N. Galiè" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa050010" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2005" "volumen" => "353" "paginaInicial" => "2148" "paginaFinal" => "2157" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16291984" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bb0110" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bosentan Improves Exercise Tolerance and Tei Index in Patients With Pulmonary Hypertension and Prostanoid Therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "H.J. Seyfarth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.128.2.709" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "709" "paginaFinal" => "713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16100158" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bb0115" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term Treatment With Oral Sildenafil in Addition to Continuous IV Epoprostenol in Patients With Pulmonary Arterial Hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "L. Stiebellehner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2003" "volumen" => "123" "paginaInicial" => "1293" "paginaFinal" => "1295" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12684325" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bb0120" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combination Of Bosentan With Epoprostenol In Pulmonary Arterial Hypertension: BRE-ATHE-2" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Humbert" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.04.00028404" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2004" "volumen" => "24" "paginaInicial" => "353" "paginaFinal" => "359" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15358690" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bb0125" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy And Safety Of Sildenafil Added To Treprostinil In Pulmonary Hyper-tension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Gomberg-Maitland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2005.06.083" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2005" "volumen" => "96" "paginaInicial" => "1334" "paginaFinal" => "1336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16253609" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "pt" "url" => "/08732159/0000001300000002/v1_201509071322/S0873215915303469/v1_201509071322/pt/main.assets" "Apartado" => array:4 [ "identificador" => "43382" "tipo" => "SECCION" "pt" => array:2 [ "titulo" => "Artigos Originais/Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "pt" ] "PDF" => "https://static.elsevier.es/multimedia/08732159/0000001300000002/v1_201509071322/S0873215915303469/v1_201509071322/pt/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915303469?idApp=UINPBA00004E" ]
Original language: Portuguese
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 10 | 10 | 20 |
2024 October | 41 | 41 | 82 |
2024 September | 24 | 46 | 70 |
2024 August | 42 | 40 | 82 |
2024 July | 32 | 39 | 71 |
2024 June | 21 | 27 | 48 |
2024 May | 28 | 28 | 56 |
2024 April | 31 | 28 | 59 |
2024 March | 32 | 27 | 59 |
2024 February | 28 | 23 | 51 |
2024 January | 17 | 24 | 41 |
2023 December | 25 | 27 | 52 |
2023 November | 20 | 18 | 38 |
2023 October | 12 | 29 | 41 |
2023 September | 26 | 35 | 61 |
2023 August | 20 | 29 | 49 |
2023 July | 18 | 29 | 47 |
2023 June | 22 | 15 | 37 |
2023 May | 15 | 30 | 45 |
2023 April | 25 | 13 | 38 |
2023 March | 30 | 25 | 55 |
2023 February | 18 | 30 | 48 |
2023 January | 22 | 25 | 47 |
2022 December | 23 | 20 | 43 |
2022 November | 31 | 28 | 59 |
2022 October | 27 | 22 | 49 |
2022 September | 14 | 31 | 45 |
2022 August | 35 | 45 | 80 |
2022 July | 18 | 23 | 41 |
2022 June | 16 | 29 | 45 |
2022 May | 33 | 31 | 64 |
2022 April | 26 | 36 | 62 |
2022 March | 28 | 24 | 52 |
2022 February | 22 | 30 | 52 |
2022 January | 25 | 38 | 63 |
2021 December | 25 | 29 | 54 |
2021 November | 15 | 35 | 50 |
2021 October | 25 | 32 | 57 |
2021 September | 21 | 21 | 42 |
2021 August | 15 | 29 | 44 |
2021 July | 19 | 19 | 38 |
2021 June | 17 | 19 | 36 |
2021 May | 20 | 21 | 41 |
2021 April | 33 | 48 | 81 |
2021 March | 27 | 21 | 48 |
2021 February | 32 | 17 | 49 |
2021 January | 25 | 9 | 34 |
2020 December | 19 | 17 | 36 |
2020 November | 44 | 23 | 67 |
2020 October | 18 | 14 | 32 |
2020 September | 41 | 33 | 74 |
2020 August | 46 | 17 | 63 |
2020 July | 48 | 19 | 67 |
2020 June | 33 | 19 | 52 |
2020 May | 64 | 17 | 81 |
2020 April | 44 | 12 | 56 |
2020 March | 41 | 18 | 59 |
2020 February | 30 | 15 | 45 |
2020 January | 40 | 10 | 50 |
2019 December | 38 | 12 | 50 |
2019 November | 42 | 11 | 53 |
2019 October | 55 | 20 | 75 |
2019 September | 39 | 20 | 59 |
2019 August | 52 | 25 | 77 |
2019 July | 35 | 10 | 45 |
2019 June | 40 | 14 | 54 |
2019 May | 48 | 25 | 73 |
2019 April | 38 | 19 | 57 |
2019 March | 44 | 18 | 62 |
2019 February | 53 | 20 | 73 |
2019 January | 51 | 14 | 65 |
2018 December | 18 | 14 | 32 |
2018 November | 9 | 9 | 18 |
2018 October | 3 | 0 | 3 |
2018 September | 10 | 4 | 14 |
2018 August | 47 | 25 | 72 |
2018 July | 37 | 22 | 59 |
2018 June | 39 | 22 | 61 |
2018 May | 52 | 14 | 66 |
2018 April | 39 | 37 | 76 |
2018 March | 43 | 26 | 69 |
2018 February | 31 | 14 | 45 |
2018 January | 22 | 15 | 37 |
2017 December | 50 | 14 | 64 |
2017 November | 34 | 10 | 44 |
2017 October | 28 | 12 | 40 |
2017 September | 42 | 13 | 55 |
2017 August | 39 | 21 | 60 |
2017 July | 19 | 16 | 35 |
2017 June | 29 | 18 | 47 |
2017 May | 39 | 7 | 46 |
2017 April | 9 | 3 | 12 |
2017 March | 19 | 18 | 37 |
2017 February | 14 | 7 | 21 |
2017 January | 16 | 4 | 20 |
2016 December | 13 | 10 | 23 |
2016 November | 10 | 9 | 19 |
2016 October | 14 | 8 | 22 |
2016 September | 5 | 7 | 12 |
2016 August | 5 | 4 | 9 |
2016 July | 3 | 2 | 5 |
2016 May | 0 | 9 | 9 |
2016 April | 2 | 7 | 9 |
2016 March | 7 | 16 | 23 |
2016 February | 5 | 13 | 18 |
2016 January | 5 | 2 | 7 |
2015 December | 7 | 2 | 9 |
2015 November | 3 | 1 | 4 |
2015 October | 2 | 2 | 4 |